Aripiprazole can a viable choice for persistant suppression of symptoms in managing chronic tic disorders and Tourette's disorder through the life span: a case series

Basit Öğe Kaydı
dc.authorid0000-0002-5652-3527en_US
dc.authorid0000-0001-5207-6240en_US
dc.authorid0000-0003-4536-1072
dc.contributor.authorTaşkıran, Sarper
dc.contributor.authorTufan, Ali Evren
dc.contributor.authorSemerci, Bengi
dc.date.accessioned2021-06-23T19:43:26Z
dc.date.available2021-06-23T19:43:26Z
dc.date.issued2016
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractTic disorders may cause impairment both by themselves and associated comorbidities. Medications for tic disorders are indicated when tics are moderate/ severe causing severe impairment and in presence of comorbid disorders responsive to medications. Duration of improvement is still not known as the literature lacks prospective studies with a long follow-up period. This case series aims to report management of tic disorders with aripiprazole in patients with different ages. Here, we describe 8 cases with complex motor tic disorder or Tourette's Disorder in which aripiprazole was used. The ages of patients were varied, from 9 to 57 years. Mean follow-up was 19.6 weeks. Mean dose of aripiprazole for pediatric patients was 15.4 mg/ day while it was 12.5 mg/ day for adult patients. All patients benefited from treatment with aripiprazole in the long term. Our results should be supported with controlled studies.en_US
dc.identifier.doi10.5455/bcp.20160220032354
dc.identifier.endpage185en_US
dc.identifier.issn1017-7833
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-84975513933en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage181en_US
dc.identifier.trdizinid201011en_US
dc.identifier.urihttps://doi.org/10.5455/bcp.20160220032354
dc.identifier.urihttps://hdl.handle.net/20.500.12491/8777
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TWpBeE1ERXhNUT09
dc.identifier.volume26en_US
dc.identifier.wosWOS:000383390400012en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorTufan, Ali Evren
dc.language.isoenen_US
dc.publisherKure Iletisim Grubu A Sen_US
dc.relation.ispartofKlinik Psikofarmakoloji Bulteni-Bulletin Of Clinical Psychopharmacologyen_US
dc.relation.publicationcategoryOlgu Sunumu - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAripiprazoleen_US
dc.subjectTicen_US
dc.subjectTourette's Disorderen_US
dc.titleAripiprazole can a viable choice for persistant suppression of symptoms in managing chronic tic disorders and Tourette's disorder through the life span: a case seriesen_US
dc.typeCase Reporten_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Aripiprazole can a Viable Choice for Persistant Suppression of Symptoms in Managing Chronic Tic Disorders and Tourette s Disorder Through the Life.pdf
Boyut:
518.91 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu